Prices delayed ≤15 min
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other
Frequently Asked Questions about TMO
What does Thermo Fisher Scientific Inc. (TMO) do?
Thermo Fisher Scientific Inc. specializes in providing comprehensive life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products. Their offerings encompass a wide range of services that cater to biopharma, healthcare, and research sectors across North America, Europe, and Asia-Pacific.
Is TMO stock a good investment in 2026?
While specific valuation metrics like P/E and revenue growth are not available, TMO's established presence in the healthcare sector and its innovative product offerings suggest potential for growth. Investors should consider the company's ability to adapt and capture market opportunities in the evolving life sciences landscape.
What is Thermo Fisher Scientific Inc.'s market capitalisation and stock price?
Currently, specific figures for Thermo Fisher Scientific's market capitalization and stock price are not available. However, it is important for investors to monitor these metrics alongside the company's 52-week high and low for a better understanding of its market position.
Does TMO pay dividends to shareholders?
Thermo Fisher Scientific does not currently pay dividends to its shareholders. Instead, the company appears to focus on reinvesting its profits into growth opportunities within the life sciences sector.
How profitable is Thermo Fisher Scientific Inc.?
Detailed profitability metrics such as net income and net margin for Thermo Fisher Scientific are not provided. However, the company's significant workforce of 125,000 employees indicates a scale that could support robust financial performance and operational efficiency.
What is TMO's P/E ratio and is the stock overvalued?
Thermo Fisher Scientific's P/E ratio is currently not available, making it challenging to conduct a traditional valuation analysis. Investors are encouraged to compare the company's growth prospects with peers in the medical diagnostics and research industry to gauge relative value.
How much debt does Thermo Fisher Scientific Inc. have?
Information regarding Thermo Fisher Scientific's debt levels is not available, including the debt-to-equity ratio. Understanding the company's balance sheet health is crucial, and investors should keep an eye on future disclosures for insights into its financial leverage.
What is TMO's 52-week trading range?
The specific 52-week trading range for TMO is not provided, leaving investors without a clear picture of its price volatility. Observing future price movements in relation to any available moving averages will be essential for assessing market trends.
Is TMO a growth stock or value stock?
Without current revenue and EPS growth data, it is difficult to classify TMO definitively as a growth or value stock. However, its focus on innovative life sciences solutions suggests characteristics of a growth stock.
What are the main risks of investing in TMO?
Investing in TMO carries specific risks, including a beta of 0.90, indicating lower volatility compared to the market. Additionally, potential competition in the healthcare sector and the absence of detailed financial metrics may pose challenges for investors.